Avalon Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-751
| Closed | -$465K | – | 149 |
|
|
2024
Q3 | $465K | Buy |
751
+354
| +89% | +$219K | 0.14% | 84 |
|
|
2024
Q2 | $220K | Buy |
397
+51
| +15% | +$28.2K | 0.07% | 113 |
|
|
2024
Q1 | $201K | Buy |
+346
| New | +$201K | 0.08% | 95 |
|
|
2019
Q4 | – | Sell |
-5,275
| Closed | -$1.54M | – | 41 |
|
|
2019
Q3 | $1.54M | Sell |
5,275
-455
| -8% | -$132K | 1.82% | 17 |
|
|
2019
Q2 | $1.68M | Sell |
5,730
-1,650
| -22% | -$485K | 1.92% | 16 |
|
|
2019
Q1 | $2.02M | Buy |
7,380
+1,870
| +34% | +$512K | 1.71% | 19 |
|
|
2018
Q4 | $1.23M | Sell |
5,510
-460
| -8% | -$103K | 1.31% | 19 |
|
|
2018
Q3 | $1.46M | Sell |
5,970
-55
| -0.9% | -$13.4K | 1.33% | 24 |
|
|
2018
Q2 | $1.25M | Buy |
+6,025
| New | +$1.25M | 1.24% | 24 |
|